New investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are demonstrating encouraging effects in addressing weight gain and type second-type condition. Animal data suggest a distinct process https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/